tetano
Editor, Senior Moderator
Am J Infect Control. 2017 Nov 14. pii: S0196-6553(17)31140-9. doi: 10.1016/j.ajic.2017.09.034. [Epub ahead of print]
[h=1]Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population.[/h] Matsushita M[SUP]1[/SUP], Takeuchi S[SUP]2[/SUP], Kumagai N[SUP]3[/SUP], Morio M[SUP]1[/SUP], Matsushita C[SUP]4[/SUP], Arise K[SUP]5[/SUP], Awatani T[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] This study aimed to examine the effects of a booster vaccination in elderly people using 2 doses of trivalent inactivated influenza vaccine during the 2012-2013 influenza epidemic. Seroprotection rates against the A(H1N1)pdm09 strain in younger elderly people (aged 61-75 years) and the A(H3N2) and B strains in both younger elderly people (aged 61-75 years) as well as very elderly people (aged 76-102 years) did not decrease at 22 weeks after vaccination. This approach confers long-lasting antibody responses and may be useful in clinical practice.
Copyright ? 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
[h=4]KEYWORDS:[/h] Seroprotection rate
PMID: 29150194 DOI: 10.1016/j.ajic.2017.09.034
[h=1]Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population.[/h] Matsushita M[SUP]1[/SUP], Takeuchi S[SUP]2[/SUP], Kumagai N[SUP]3[/SUP], Morio M[SUP]1[/SUP], Matsushita C[SUP]4[/SUP], Arise K[SUP]5[/SUP], Awatani T[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] This study aimed to examine the effects of a booster vaccination in elderly people using 2 doses of trivalent inactivated influenza vaccine during the 2012-2013 influenza epidemic. Seroprotection rates against the A(H1N1)pdm09 strain in younger elderly people (aged 61-75 years) and the A(H3N2) and B strains in both younger elderly people (aged 61-75 years) as well as very elderly people (aged 76-102 years) did not decrease at 22 weeks after vaccination. This approach confers long-lasting antibody responses and may be useful in clinical practice.
Copyright ? 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
[h=4]KEYWORDS:[/h] Seroprotection rate
PMID: 29150194 DOI: 10.1016/j.ajic.2017.09.034